Lasa Supergenerics Limited (BOM:540702)
India
· Delayed Price · Currency is INR 12.55
-0.65 (-4.92%)
At close: Jun 13, 2025
Lasa Supergenerics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2020 |
| Operating Revenue | 1,424 | 1,043 | 1,296 | 1,371 | 2,024 | Upgrade
|
| Other Revenue | 50.12 | 0.75 | 8.62 | - | - | Upgrade
|
| Revenue | 1,475 | 1,044 | 1,304 | 1,371 | 2,024 | Upgrade
|
| Revenue Growth (YoY) | 41.23% | -19.95% | -4.88% | -32.24% | 21.00% | Upgrade
|
| Cost of Revenue | 1,062 | 773.72 | 1,075 | 897.68 | 1,163 | Upgrade
|
| Gross Profit | 412.73 | 270.38 | 229.09 | 473.59 | 860.47 | Upgrade
|
| Selling, General & Admin | 61.08 | 66.43 | 79.64 | 73.77 | 144.82 | Upgrade
|
| Other Operating Expenses | 238.87 | 180.79 | 187.62 | 207.24 | 243 | Upgrade
|
| Operating Expenses | 422.95 | 353.95 | 401.45 | 426.12 | 546.06 | Upgrade
|
| Operating Income | -10.22 | -83.57 | -172.36 | 47.47 | 314.41 | Upgrade
|
| Interest Expense | -26.92 | -19.74 | -41.54 | -0.25 | -16.76 | Upgrade
|
| Interest & Investment Income | - | 0.25 | 0.27 | 0.85 | 0.49 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.16 | -16.42 | -7.3 | 1.17 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0.18 | -0.36 | -0.28 | -3.8 | Upgrade
|
| EBT Excluding Unusual Items | -37.14 | -103.39 | -230.41 | 40.5 | 295.52 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.5 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 6.72 | 0.94 | -0.1 | Upgrade
|
| Asset Writedown | - | -23.22 | - | - | - | Upgrade
|
| Other Unusual Items | -156.69 | -64.51 | -198.97 | -102.83 | - | Upgrade
|
| Pretax Income | -193.83 | -191.13 | -422.65 | -61.39 | 294.91 | Upgrade
|
| Income Tax Expense | -46.26 | 26.18 | -36.44 | -8.08 | 67.14 | Upgrade
|
| Net Income | -147.57 | -217.31 | -386.21 | -53.31 | 227.78 | Upgrade
|
| Net Income to Common | -147.57 | -217.31 | -386.21 | -53.31 | 227.78 | Upgrade
|
| Net Income Growth | - | - | - | - | 527.76% | Upgrade
|
| Shares Outstanding (Basic) | 50 | 50 | 50 | 50 | 41 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 50 | 50 | 50 | 41 | Upgrade
|
| Shares Change (YoY) | -0.15% | - | -0.39% | 23.66% | - | Upgrade
|
| EPS (Basic) | -2.95 | -4.34 | -7.71 | -1.06 | 5.60 | Upgrade
|
| EPS (Diluted) | -2.95 | -4.34 | -7.71 | -1.06 | 5.60 | Upgrade
|
| EPS Growth | - | - | - | - | 529.21% | Upgrade
|
| Free Cash Flow | -28.24 | 21.39 | -173 | 92.12 | 347.24 | Upgrade
|
| Free Cash Flow Per Share | -0.56 | 0.43 | -3.45 | 1.83 | 8.54 | Upgrade
|
| Dividend Per Share | - | - | - | 0.250 | 0.250 | Upgrade
|
| Gross Margin | 27.99% | 25.90% | 17.56% | 34.54% | 42.52% | Upgrade
|
| Operating Margin | -0.69% | -8.00% | -13.21% | 3.46% | 15.54% | Upgrade
|
| Profit Margin | -10.01% | -20.81% | -29.61% | -3.89% | 11.25% | Upgrade
|
| Free Cash Flow Margin | -1.92% | 2.05% | -13.26% | 6.72% | 17.16% | Upgrade
|
| EBITDA | 112.78 | 23.16 | -38.17 | 192.58 | 472.65 | Upgrade
|
| EBITDA Margin | 7.65% | 2.22% | -2.93% | 14.04% | 23.36% | Upgrade
|
| D&A For EBITDA | 123 | 106.73 | 134.19 | 145.11 | 158.24 | Upgrade
|
| EBIT | -10.22 | -83.57 | -172.36 | 47.47 | 314.41 | Upgrade
|
| EBIT Margin | -0.69% | -8.00% | -13.21% | 3.46% | 15.54% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 22.77% | Upgrade
|
| Revenue as Reported | 1,475 | 1,044 | 1,314 | 1,374 | 2,024 | Upgrade
|
| Advertising Expenses | - | 0.66 | 3.24 | 0.34 | 0.5 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.